Patents Examined by Mark V Stevens
  • Patent number: 11065192
    Abstract: A mascara composition includes a film-forming polymer portion. The film-forming polymer portion is stabilized in a vehicle that includes water. The film-forming polymer portion includes a high molecular weight vinylpyrrolidone homopolymer and an acrylic polymer having a glass transition temperature of 65° C. or more. The mascara composition includes at least about 10 percent by weight of the vinylpyrrolidone homopolymer and is substantially free of wax. Methods of applying makeup to the eyelashes are also provided.
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: July 20, 2021
    Assignee: L'OREAL
    Inventors: Jody Ebanks, Christopher Pang, Christopher Michael MacNeill, Tsang-Min Huang
  • Patent number: 11065187
    Abstract: A method for forming a photosensitizer product that is resistant to absorption by living tissue that may include binding a photosensitizer compound with an oxide-containing particle to provide the photosensitizer derivative having a microscale size, and mixing the photosensitizer derivative into a lotion. The microscale size of the photosensitizer derivative obstructs absorption by cell tissue.
    Type: Grant
    Filed: July 16, 2019
    Date of Patent: July 20, 2021
    Assignee: International Business Machines Corporation
    Inventors: Scott B. King, Brandon M. Kobilka, Joseph Kuczynski, Jacob T. Porter, Jason T. Wertz
  • Patent number: 11052084
    Abstract: The present disclosure relates to pharmaceutical capsules comprising lumateperone, in free, or pharmaceutically acceptable salt form, optionally in combination with one or more additional therapeutic agents, processes for manufacture thereof and methods of use in the treatment or prophylaxis of disease.
    Type: Grant
    Filed: June 16, 2020
    Date of Patent: July 6, 2021
    Assignee: INTRA-CELLULAR THERAPIES, INC.
    Inventors: Peng Li, Robert Davis
  • Patent number: 11052108
    Abstract: The present invention provides compositions and methods of treating a leukemia, including chronic lymphocytic leukemia, wherein the method comprises administering a stabilized amorphous calcium carbonate to a person in need thereof.
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: July 6, 2021
    Assignee: AMORPHICAL LTD.
    Inventor: Yosef Ben
  • Patent number: 11046643
    Abstract: Provided are compounds described by the Formula I: wherein: R1 is a linear or branched, saturated or unsaturated aliphatic group having from 5 to 22 carbon atoms; R2 is selected from the group consisting of the functional groups: and salts thererof; n is from 0 to 4; and R3 is a linear or branched, saturated or unsaturated aliphatic group having from 1 to 6 carbon atoms. Also provided are compositions comprising, and methods of use of, the compounds of the present invention.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: June 29, 2021
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Robert J. Gambogi, Anthony R. Geonnotti, III, Michael C. Giano, Latrisha Petersen
  • Patent number: 11045422
    Abstract: An abuse resistant oral pharmaceutical composition, comprising: a barrier layer, comprising a first polymer; a diffusion layer, comprising a second polymer, substantially covering the barrier layer, wherein the diffusion layer is bonded to the barrier layer and comprises a drug that is substantially homogeneously distributed within the second polymer and diffuses from the diffusion layer within the gastrointestinal (GI) tract; and optionally an expansion layer comprising an expandable polymer, wherein the expansion layer is substantially covered by the barrier layer. Methods of making the same and methods of using the same are also provided.
    Type: Grant
    Filed: March 4, 2011
    Date of Patent: June 29, 2021
    Assignee: OHENO LIFE SCIENCES, INC.
    Inventors: Manish S. Shah, Ray Difalco
  • Patent number: 11040066
    Abstract: The present disclosure relates to topical compositions comprising water, solvent, thickener, preservative and conditioning agent wherein the composition has a viscosity approximately in the range 200-6000 cP at 25° C. following exposure to gamma radiation, to use of the composition in a dressing and the use of compositions and dressings in treatment or prophylaxis of burns.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: June 22, 2021
    Assignee: Safeguard Medical Holdco, LLC
    Inventor: Mark Lait
  • Patent number: 11033504
    Abstract: The invention relates to a film-forming composition comprising a fluidised hydroxypropyl starch and sorbitol, and to a film-coating method using said composition. The invention further relates to film-coated solid forms comprising a fluidised hydroxypropyl starch and sorbitol in the coating.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: June 15, 2021
    Assignee: ROQUETTE FRERES
    Inventors: Xavier Parissaux, Gregory Le Bihan, Sebastien Croquet
  • Patent number: 11033488
    Abstract: There is provided in accordance with an exemplary embodiment of the invention, a device and a method for controlled extraction of at least one active substance from at least one type of plant matter by application of heat, the device comprising: a heating element adapted to apply heat to an area of the plant matter to extract the substance; and a mechanism adapted for moving the plant matter relative to the heating element. Optionally, the active substance is a restricted substance. There is also provided in accordance with an exemplary embodiment of the invention, a method of monitoring and controlling inhalation of a restricted substance. There is provided in accordance with an exemplary embodiment of the invention, a method of manufacturing a tape of plant matter comprising an active substance.
    Type: Grant
    Filed: August 30, 2017
    Date of Patent: June 15, 2021
    Assignee: Syqe Medical Ltd.
    Inventors: Perry Davidson, Aaron Schorr, Arie Holtz, Will Pong, Binyamin Schwartz
  • Patent number: 11020356
    Abstract: The patch of the present invention comprises a backing layer and an adhesive layer laminated on the backing layer, wherein a water vapor transmission rate of the backing layer is 400 g/m2·24 hours or more, and the adhesive layer comprises a drug, dimethylsulfoxide and an adhesive. Such a patch does not fall off easily even after long wear.
    Type: Grant
    Filed: December 26, 2017
    Date of Patent: June 1, 2021
    Assignee: HISAMITSU PHARMACEUTICAL CO., INC.
    Inventors: Ryo Tanaka, Hideaki Ohashi, Naruhide Miyoshi, Takito Shima, Naoko Fujita, Yasunari Michinaka
  • Patent number: 11013720
    Abstract: Disclosed herein is a ganetespib-containing particle, which includes an active ingredient selected from ganetespib, a pharmaceutically acceptable salt of ganetespib, and a combination thereof, and an amphiphilic chitosan-based carrier carrying the active ingredient. Also disclosed herein are a pharmaceutical composition including the ganetespib-containing particle, and use of such pharmaceutical composition in treating cancer.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: May 25, 2021
    Assignee: NATIONAL CHIAO TUNG UNIVERSITY
    Inventors: Yan-Hwa Wu Lee, Dean-Mo Liu, Wei-Ting Huang, Ru-Tsun Mai, Yi-Hsin Chen
  • Patent number: 11007279
    Abstract: A major challenge in non-viral gene delivery remains finding a safe and effective delivery system. Colloidally stable non-viral gene vector delivery systems capable of overcoming various biological barriers, are disclosed. The gene vectors are biodegradable, non-toxic and highly tailorable for use in specific applications. The vectors include a mixture of biodegradable copolymers, such as PBAE, and biodegradable polymers conjugated with hydrophilic, neutrally charged polymer, such as PEG. The gene vectors demonstrate broad vector distribution and high transgene delivery in vivo, providing an efficient non-viral gene delivery system for localized therapeutic gene transfer. Methods of using the vectors to overcome biological barriers including mucus gel and extracellular matrix are provided. Methods of formulating the vectors are also provided.
    Type: Grant
    Filed: June 4, 2019
    Date of Patent: May 18, 2021
    Assignee: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Justin Hanes, Jung Soo Suk, Panagiotis Mastorakos
  • Patent number: 11007216
    Abstract: Techniques regarding enhancing antimicrobial activity of antirheumatic agents by combination therapy are provided. For example, one or more embodiments described herein can regard a chemical composition comprising a polycarbonate polymer functionalized with a guanidinium functional group. The chemical composition can also comprise an antirheumatic agent, and the polycarbonate polymer can enhance an antimicrobial activity of the antirheumatic agent.
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: May 18, 2021
    Assignees: INTERNATIONAL BUSINESS MACHINES CORPORATION, AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: James L. Hedrick, Yi Yan Yang, Xin Ding, Chuan Yang
  • Patent number: 11007179
    Abstract: Abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-4,5-dihydro-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, and processes for the preparation and administration of these formulations.
    Type: Grant
    Filed: October 8, 2020
    Date of Patent: May 18, 2021
    Assignee: Allergan Holdings Unlimited Company
    Inventors: Tim Costello, Jens Jozef Ceulemans, Eugeen Maria Jozef Jans, Philip Erna H. Heyns
  • Patent number: 11000544
    Abstract: A trace element solution comprises at least the following metals: zinc; manganese; selenium; and copper; and which comprises a concentration of the metals of at least 90 mg/ml. The solution may comprise the following concentrations: at least 60 mg/ml zinc; at least 10 mg/ml manganese; at least 5 mg/ml selenium; and at least 15 mg/ml copper. The solution may comprise chromium, iodine and chromium.
    Type: Grant
    Filed: June 3, 2019
    Date of Patent: May 11, 2021
    Assignee: Warburton Technology Limited
    Inventor: William Alfred Smith
  • Patent number: 10993909
    Abstract: A composition and method for treating a mammal infected with a virus therein, and an inhalation delivery system for prevention and treatment of upper respiratory tract viruses, by administering a therapeutic dose of the composition to the mammal. The composition includes: microparticles and/or nanoparticles, wherein a pharmaceutically active agent, corticosteroid and/or hydroxychloroquine, niclosamide, and/or favipiravir, and a zinc salt are incorporated in the microparticles and/or nanoparticles. The pharmaceutically active agent is unfractionated heparin (UFH), Low Molecular Weight Heparin (LMWH), sulfated non-anticoagulant heparin (S-NACH), other glycosaminoglycans (GAGs), or combinations thereof.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: May 4, 2021
    Assignee: Virothera Pharmaceuticals LLC
    Inventor: Shaker A. Mousa
  • Patent number: 10987448
    Abstract: Aspects of the present invention provide implants for augmentation, stabilization, or defect reconstruction of bone tissue, comprising a scaffold portion structured to provide shape to the implant, the scaffold portion comprising one or more of the following: one or more polylactic acid isomer; one or more polyglycolic acid isomer; and/or allogenic bone material, or similar compound.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: April 27, 2021
    Assignee: UNIVERSITY OF SOUTH FLORIDA
    Inventors: Jessica A. Ching, Jonathan Michael Ford, Summer Joy Decker
  • Patent number: 10980739
    Abstract: This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: April 20, 2021
    Assignee: Progenity, Inc.
    Inventors: Mitchell Lawrence Jones, Christopher Loren Wahl, Sharat Singh, Harry Stylli, Allison Luo
  • Patent number: 10973756
    Abstract: Sand is an irritant to people and animals. The application of the sand remover powder mixture consisting of 40% montmorillonite and 60% Maranta arundinacea and rubbed/wiped removes sand from effected areas of skin and hair on humans and animals better together than in their individual natural state. In some embodiments sand remover powder can contain fragrance. Sand remover powder and rubbing/wiping can be used to remove residue from hair. Sand remover powder can be used as a body powder. Some sand remover powder embodiments can be ingested.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: April 13, 2021
    Inventors: Marla Christianne Deck, David Aaron Deck
  • Patent number: 10960022
    Abstract: A three component composition for use in the treatment of an autoimmune disease where the first component comprises a bimodal synthetic carbon particle mixture; the second component comprises a bimodal synthetic carbon particle mixture and an anion exchange resin and the third component comprises a bimodal synthetic carbon particle mixture and a cation exchange resin.
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: March 30, 2021
    Assignee: Immutrix Therapeutics, Inc.
    Inventors: Carol A Rae, Jan Simoni, Grace Simoni, John F. Moeller